Literature DB >> 11967010

Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose.

Farhad Amiri1, Seán Shaw, Xiaodan Wang, Jie Tang, Jennifer L Waller, Douglas C Eaton, Mario B Marrero.   

Abstract

BACKGROUND: Both high glucose (HG) and angiotensin II (Ang II) causes glomerular mesangial cell (GMC) growth and increased synthesis of matrix proteins like collagen IV contributing to diabetic nephropathy. We have recently found that exposure of vascular smooth muscle cells to HG augments the Ang II activation of the growth promoting JAK/STAT pathway. We hypothesized that Ang II activation of the JAK/STAT pathway is altered by HG in GMC, and that this pathway might be linked to the Ang II-induced growth and overproduction of collagen IV in GMC in HG conditions.
METHODS: GMC were cultured under normal glucose (NG; 5.5 mmol/L) and HG (25 mmol/L) for 48 hours and stimulated with Ang II (0.1 micromol/L) for various times. GMC lysate was then immunoprecipitated and/or immunoblotted with SHP-1, SHP-2 and phosphospecific JAK2 and STAT antibodies. The HG and Ang II induced growth and collagen IV synthesis studies were performed in GMC transfected with JAK2 antisense or JAK2 sense. GMC growth was monitored via [3H]-thymidine incorporation, and collagen IV synthesis via ELISA.
RESULTS: We found that Ang II-induced JAK2, STAT1, STAT3, STAT5A/B and SHP-2 phosphorylations were enhanced by HG, whereas that of SHP-1 was reduced. Ang II-induced growth and collagen IV synthesis also were increased under HG conditions. Transfection of GMC with JAK2 antisense oligonucleotides blocked the Ang II-induced growth and collagen IV synthesis in both NG and HG conditions.
CONCLUSION: These results provide evidence that activation of the JAK/STAT pathway by HG or/and Ang II may be of importance in the increased GMC cell growth and collagen IV synthesis that is seen in diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967010     DOI: 10.1046/j.1523-1755.2002.00311.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  46 in total

Review 1.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

2.  Enhanced angiotensin-converting enzyme 2 attenuates angiotensin II-induced collagen production via AT1 receptor-phosphoinositide 3-kinase-Akt pathway.

Authors:  Le Bu; Shen Qu; Xiang Gao; J-J Zou; Wei Tang; L-L Sun; Z-M Liu
Journal:  Endocrine       Date:  2010-12-28       Impact factor: 3.633

3.  Glucagon receptor-mediated extracellular signal-regulated kinase 1/2 phosphorylation in rat mesangial cells: role of protein kinase A and phospholipase C.

Authors:  Xiao C Li; Oscar A Carretero; Yuan Shao; Jia L Zhuo
Journal:  Hypertension       Date:  2006-01-03       Impact factor: 10.190

4.  Angiotensin II utilizes Janus kinase 2 in hypertension, but not in the physiological control of blood pressure, during low-salt intake.

Authors:  Amy K L Banes-Berceli; Hind Al-Azawi; Daniel Proctor; Harvey Qu; Dominic Femminineo; Crystal Hill-Pyror; R Clinton Webb; Michael W Brands
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

Review 5.  From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.

Authors:  Ying Qian; Eva Feldman; Subramanian Pennathur; Matthias Kretzler; Frank C Brosius
Journal:  Diabetes       Date:  2008-06       Impact factor: 9.461

6.  Fluorofenidone protects against renal fibrosis by inhibiting STAT3 tyrosine phosphorylation.

Authors:  Juan Tang; Chun-yan Liu; Miao-miao Lu; Jing Zhang; Wen-juan Mei; Wen-jun Yang; Yan-yun Xie; Ling Huang; Zhang-zhe Peng; Qiong-jing Yuan; Ji-shi Liu; Gao-yun Hu; Li-jian Tao
Journal:  Mol Cell Biochem       Date:  2015-06-02       Impact factor: 3.396

7.  Janus Kinase 2 Regulates Transcription Factor EB Expression and Autophagy Completion in Glomerular Podocytes.

Authors:  Tamadher A Alghamdi; Syamantak Majumder; Karina Thieme; Sri N Batchu; Kathryn E White; Youan Liu; Angela S Brijmohan; Bridgit B Bowskill; Suzanne L Advani; Minna Woo; Andrew Advani
Journal:  J Am Soc Nephrol       Date:  2017-04-19       Impact factor: 10.121

Review 8.  Inflammation in diabetic kidney disease.

Authors:  Patricia M García-García; María A Getino-Melián; Virginia Domínguez-Pimentel; Juan F Navarro-González
Journal:  World J Diabetes       Date:  2014-08-15

9.  Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy.

Authors:  Ting-Chi Lu; Zhao-Hui Wang; Xiaobei Feng; Peter Y Chuang; Wei Fang; Yuhong Shen; David E Levy; Huabao Xiong; Nan Chen; John Cijiang He
Journal:  Kidney Int       Date:  2009-04-08       Impact factor: 10.612

Review 10.  The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal disease.

Authors:  Futoshi Matsui; Kirstan K Meldrum
Journal:  J Surg Res       Date:  2012-07-17       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.